News

Upcoming Financial Releases for Svitzer in 2025 Explained

Upcoming Financial Releases for Svitzer in 2025 Explained

Important Dates for Svitzer Group’s Financial Calendar 2025

As we approach the new year, it's vital for investors, stakeholders, and interested parties to stay informed about Svitzer Group’s forthcoming financial disclosures. This article outlines the key release dates for financial announcements to help you prepare and stay updated.

Finance Release Schedule

Svitzer Group, recognized for its international towing and marine services, has slated several important dates throughout 2025 for financial communications. These include the annual report, general meetings, and quarterly trading updates.

April Highlights

The company will publish its annual report on March 5, presenting the financial performance for the previous year, followed by the Annual General Meeting set for April 10. This is an essential gathering where shareholders can discuss previous results and vote on key decisions for the company's future.

May Trading Statement

In May, the company will release its trading statement for the first quarter on May 15. This document will provide insight into the company's financial health and initial performance indicators for 2025, crucial for shareholder evaluations and market predictions.

Mid-Year Reports

The financial calendar features a significant update in August with the release of the Interim Report for the first half of the year, scheduled for August 26. This report will be critical in assessing how well Svitzer is performing against its goals.

End of Year Responsibilities

As the year approaches its close, the third-quarter trading statement will be released on November 13. This statement will offer a performance check and highlight any shifts in strategy or operations that have occurred throughout the fourth quarter.

Shareholder Proposals for AGM

Shareholders keen on suggesting items for discussion at the Annual General Meeting must submit their proposals by February 27, 2025. Submissions should be directed to the Investor Relations email at ir@svitzer.com, ensuring that all voices are heard during this critical business event.

Contact Information for Shareholders

For any inquiries related to these financial events, Svitzer encourages shareholders and potential investors to reach out directly:

Michael Nass Nielsen, Head of Investor Relations and FP&A
T: +45 24941654
E: ir@svitzer.com

Anders Crillesen, Global Head of Communications
T: +45 27791286
E: anders.crillesen@svitzer.com

Understanding Svitzer’s Role in Marine Services

Svitzer is at the forefront of marine operations, aiding substantial vessels as they navigate critical points of entry in ports and terminals globally. With a fleet exceeding 450 vessels, Svitzer holds a significant position within port infrastructure, working diligently to ensure safe and efficient operations at sea.

As of now, Svitzer services about 2,000 customers across 140 ports and 40 terminals in 37 countries. Established in 1833, the company has built a legacy based on reliability and expertise in marine logistics.

Frequently Asked Questions

What are the key dates for Svitzer's financial announcements in 2025?

Svitzer's key dates include the Annual Report on March 5, the AGM on April 10, Q1 Trading Statement on May 15, Interim Report on August 26, and Q3 Trading Statement on November 13.

How can shareholders submit proposals for the AGM?

Shareholders may submit their proposals via email to ir@svitzer.com by February 27, 2025.

What role does Svitzer play in the marine industry?

Svitzer provides towage and marine services, facilitating the safe movement of large vessels in ports and terminals, essential to maritime logistics.

Who can I contact for more information about Svitzer's financial calendar?

For inquiries, contact Michael Nass Nielsen or Anders Crillesen using the provided emails for Investor Relations and Communications.

When is the Interim Report for H1 2025 scheduled to be released?

The Interim Report for the first half of 2025 is scheduled for release on August 26, 2025.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

New Leadership Fuels Expansion of Black Optix Tint

Updated Category News Views 90

Shifting Gears with New Leadership Black Optix Tint isn't just revamping its car-styling game; it's refueling the entire brand with the appointment of Jeff Stark as its new brand president. This guy's entry into the picture is like putting nitro in the tank of a franchise that's already got some serious road miles behind it. With over 15 years under his belt in the...

Continue Reading
Greenworks Giveaway Powers Lawn Pros with $34K in Gear

Updated Category News Views 45

Big Wins for Small Operations: The Greenworks Gamble Here's something that'll make any grass-whisperer perk up. Greenworks® Commercial, known for their battery-centered machinery, juiced some serious goodwill at the Equip Exposition 2026. They coughed up nearly $34,000 in gear, dishing out prizes like really expensive candy at a lawn-care carnival. Lucky Draw Brings...

Continue Reading
Kim Dunbar Sheds Light on Online Personalized Learning

Updated Category News Views 71

Picture a classroom without walls, the teacher always available, and students moving at their own pace. Sounds utopian, right? Well, Virtual Public School Expert Kim Dunbar is making sense of this approach at SC Whitmore School in Columbia, South Carolina, as she explains how this works in an online high school. Mastery-Based Learning: Beyond the Conventional Rigid...

Continue Reading
Xi's Financial Vision: China's Path to Global Power

Updated Category News Views 0

China's Grand Financial Strategy Alright, strap in as President Xi Jinping is back on the scene painting a bold picture for China's financial future. The guy doesn't mess around when he says finance is a linchpin for the country's modernization. China's got the pedal to the metal, aiming to transform its national clout into a financial juggernaut. Key Pillars of Financial...

Continue Reading
EClinCloud Targets Better FDA Compliance with AI Boost

Updated Category News Views 16

FDA Citations Under the Microscope Here we are, wading through another layer of clinical research nitty-gritty, and it's bringing clinical processes under a sharper lens. EClinCloud just dropped a hefty analysis on 1,715 FDA Bioresearch Monitoring citations. Turns out, protocol compliance, informed consent, and case histories chew up 46.2% of these citations. Sounds like...

Continue Reading
SPECS Framework: Rethinking Career Growth Strategies

Updated Category News Views 39

An Evolving Workplace Demands Evolving Strategies Look, careers ain't what they used to be—and they shouldn't be. Today’s world is flipping the script on how we work, and Dr. Brandi R. Muñoz is rewriting the book on career development with her SPECS framework. The guy clinging to his outdated Rolodex for advice isn't gonna cut it anymore. "Who Are Your SPECS?...

Continue Reading
Northwind Backs Huge Office-to-Residential Overhaul

Updated Category News Views 159

In the Heart of Midtown: A Major Overhaul I'm telling ya, if there's a piece of news that makes me sit up straight this morning over the breakfast bar, it's this colossal $231 million construction loan announcement by Northwind Group. They're turning 675 Third Avenue, a towering 32-story office behemoth smack in Midtown, into residential apartments. Right here in...

Continue Reading
Summit Midstream Prepares for Q3 2026 Earnings Report

Updated Category News Views 40

Quarterly financials are the canary in the coal mine for any energy firm. Scrutinizing those numbers can be the difference between riding a bull market or nursing your wounds in a ditch. So, what's on tap for Summit Midstream Corporation (NYSE: SMC)? They've circled November 9, 2026, on the calendar for releasing their third quarter figures, just after the NYSE bell...

Continue Reading
Ultima Genomics Drives Precision Medicine Forward in Singapore

Updated Category News Views 0

A Major Milestone for Precision Medicine Ultima Genomics just nabbed a big one, folks. They're going front and center with Singapore's National Precision Medicine (NPM) Program for Phase III, marking no small feat in the ambitious world of genomics. This is more than just another feather in their cap—it's a power move in the cutthroat race for sequencing supremacy. And...

Continue Reading
YOUTOPIA Fashion Final Fuels Chinese Creative Growth

Updated Category News Views 63

A Melting Pot of Chinese Creative Talent Under the neon glow of Shanghai’s iconic skylines, the 2026 YOUTOPIA Fashion Final became a buzzing hive of creative energy — the kind that prickles your skin and makes you lean in. This ain't just about strutting pretty threads; it's the crucible for tomorrow's fashion titans, the place where raw talent gets its first taste of...

Continue Reading

Top 5 Most Recently Viewed Articles

Exousia Bio Advances Cancer Therapy with New Acquisition

Updated Category News Views 181

Exousia Bio Completes Strategic Acquisition In a significant move for the oncology sector, LAMY announced that it has finalized the acquisition of Exousia AI, Inc., expanding its prowess in exosome-based cancer therapies. This strategic maneuver, which involved the issuance of 62,223,000 shares of common stock, positions the company to leverage a promising preclinical...

Continue Reading
Getaround's Strategic Focus Shift: A Closer Look at Operations

Updated Category News Views 554

Getaround's Strategic Decision to Wind Down U.S. Operations Getaround, Inc., a notable player in the global car-sharing landscape, has made the tough decision to initiate an organized wind-down of its United States business operations. This strategic move will encompass both its car-share services and the HyreCar division, while continuing to strengthen and expand its...

Continue Reading
Pharmacists Mutual Insurance Company Transforms Into Group Structure

Updated Category News Views 294

Exciting Developments for Pharmacists Mutual Insurance Company Pharmacists Mutual Insurance Company, known for its leadership in commercial property and casualty insurance, is embarking on a significant transformation aimed at enhancing its service offerings and operational flexibility. The company is thrilled to announce its restructuring into a limited mutual holding...

Continue Reading
Winsome Resources Advances with Adina Lithium Project Permit Filing

Updated Category News Views 257

Winsome Resources Takes Step Forward with Adina Project Winsome Resources, a company dedicated to lithium exploration and development, proudly announces the submission of the Preliminary Information Statement for its Adina Lithium Project. This pivotal step has been taken in collaboration with the relevant authorities, marking the beginning of a refined provincial...

Continue Reading
Hoth Therapeutics Pioneers Drug-Induced Rash Treatment Solutions

Updated Category News Views 188

Hoth Therapeutics Innovates with HT-001 for Patient Care Hoth Therapeutics is making significant strides in oncology with its innovative drug HT-001, meticulously developed to ease dermatological side effects associated with MENIN inhibitors, a class of oncology drugs gaining traction in treating acute leukemias and specific solid tumors. The aim is to allow patients to...

Continue Reading